POMDOCTOR to End ADR Program and Consolidate Shares
POMDOCTOR will terminate its ADR program before the market opens on Oct. 21, 2026, and list Class A ordinary shares on Nasdaq. Each 10 ADSs will become 3 post-consolidation Class A shares.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.